We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Bioprinting 3D Technology Mimics Liver to Detoxify Blood

By LabMedica International staff writers
Posted on 27 May 2014
Nanoengineers have developed a three-dimensional (3D)-printed device to act like the liver to remove harmful toxins from the blood. More...
The device, which is designed to be used outside the body, similar to dialysis, utilizes nanoparticles to trap pore-forming toxins that can injure cellular membranes and are a major factor in disorders that result from stings, animal bites, and bacterial infections.

The study’s findings were published May 8, 2014, in the journal Nature Communications. Nanoparticles have already been shown to be effective at neutralizing pore-forming toxins in the blood, but if those nanoparticles cannot be effectively digested, they can accumulate in the liver creating a risk of secondary poisoning, particularly among patients who are already at risk of liver failure. To resolve this problem, a team of investigators, led by University of California, San Diego’s (UCSD; USA) nanoengineering Prof. Shaochen Chen devised a 3D-printed hydrogel matrix to hold nanoparticles, forming a device that mimics the function of the liver by sensing, attracting, and capturing toxins channeled from the blood.

The device, which is in the proof-of-concept phase, replicates the structure of the liver but has a larger surface area designed to effectively lure and trap toxins within the device. In an in vitro study, the device totally neutralized pore-forming toxins. “One unique feature of this device is that it turns red when the toxins are captured,” said the co-first author, Xin Qu, who is a postdoctoral researcher working in Prof. Chen’s laboratory. “The concept of using 3D printing to encapsulate functional nanoparticles in a biocompatible hydrogel is novel,” said Prof. Chen. “This will inspire many new designs for detoxification techniques since 3D printing allows user-specific or site-specific manufacturing of highly functional products.”

Prof. Chen’s lab has already validated the ability to print complex 3D microstructures, such as blood vessels, in only seconds out of soft biocompatible hydrogels that contain living cells.

Related Links:

University of California, San Diego



Gold Member
Veterinary Hematology Analyzer
Exigo H400
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Celiac Disease Test
Anti-Gliadin IgG ELISA
New
Specimen Radiography System
TrueView 200 Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
Image: Pancreatic cancer diagnosis (Photo courtesy of World Journal of Gastroenterology)

AI-Driven Preliminary Testing for Pancreatic Cancer Enhances Prognosis

Pancreatic cancer poses a major global health threat due to its high mortality rate, with 467,409 deaths and 510,992 new cases reported worldwide in 2022. Often referred to as the "king" of all cancers,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.